Literature DB >> 1733550

In vitro succinate dehydrogenase chemosensitivity of gastric carcinoma--relationship to DNA content.

A Saito1, D Korenaga, Y Maehara, H Baba, T Okamura, K Sugimachi.   

Abstract

Relationships between in vitro chemosensitivity and cell nuclear DNA content were investigated in malignant cells from 41 patients exhibiting advanced gastric carcinoma. The chemosensitivity was evaluated by measuring the succinate dehydrogenase (SD) activity in drug-exposed cancer cells and the DNA content was microspectrophotometrically determined. Following exposure of malignant tissue to carboquone (CQ) and cisplatin (DDP), the mean SD activity in cells displaying a relatively regular DNA distribution (type II) was significantly higher than that in those exhibiting a widely scattered DNA distribution (type IV; P less than 0.01 in CQ, P less than 0.05 in DDP). A similar tendency was recognized in cells that were treated with aclacinomycin A (ACR), Adriamycin (ADM), and mitomycin C (MMC). Such a decrease in SD activity in cells exhibiting a type IV pattern was remarkable, especially in cases undifferentiated adenocarcinoma. Mitotic counting analysis revealed a significantly higher value for DNA pattern type IV as compared with the findings for type II (P less than 0.01). These results demonstrate that gastric carcinoma displaying a high malignant potentially shows a better response to antitumor drugs. Adjuvant chemotherapy prescribed following drug-sensitivity testing should be effective against such tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733550     DOI: 10.1007/bf00686250

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  31 in total

1.  Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma.

Authors:  D M Dent; M V Madden; S K Price
Journal:  Br J Surg       Date:  1988-02       Impact factor: 6.939

2.  Advanced gastric cancer and prognosis.

Authors:  C A Pagnini; M Rugge
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

3.  Clinical studies on a new screening assay for anticancer agents using nude mice and isotopic evaluation.

Authors:  Y Noso; K Niimi; M Nishiyama; N Hirabayashi; T Toge; M Niimoto; T Hattori
Journal:  Cancer Res       Date:  1987-12-01       Impact factor: 12.701

4.  Chemosensitivity testing of human solid tumors. A review of 1582 assays with 258 clinical correlations.

Authors:  C A Bertelsen; V K Sondak; B D Mann; E L Korn; D H Kern
Journal:  Cancer       Date:  1984-03-15       Impact factor: 6.860

5.  Accurate prognostic value of morphovolumetric analysis of advanced carcinoma of the stomach.

Authors:  M Haraguchi; T Okamura; K Sugimachi
Journal:  Surg Gynecol Obstet       Date:  1987-04

6.  Prediction of response of tumor and host to cancer chemotherapy.

Authors:  T Kondo
Journal:  Natl Cancer Inst Monogr       Date:  1971-12

7.  Partial hepatectomy alters sensitivity of rat hepatocytes to 5-fluorouracil.

Authors:  Y Maehara; H Anai; R Tamada; K Sugimachi
Journal:  Cancer Lett       Date:  1986-06       Impact factor: 8.679

8.  Comparison between succinate dehydrogenase inhibition test and subrenal capsule assay for chemosensitivity testing.

Authors:  H Anai; Y Maehara; H Kusumoto; K Sugimachi
Journal:  Oncology       Date:  1987       Impact factor: 2.935

9.  DNA ploidy is closely linked to tumor invasion, lymph node metastasis, and prognosis in clinical gastric cancer.

Authors:  D Korenaga; T Okamura; A Saito; H Baba; K Sugimachi
Journal:  Cancer       Date:  1988-07-15       Impact factor: 6.860

10.  The two-wavelength method of microspectrophotometry. II. A set of tables to facilitate the calculations.

Authors:  M L MENDELSOHN
Journal:  J Biophys Biochem Cytol       Date:  1958-07-25
View more
  1 in total

1.  Laser flow cytometric studies on the intracellular accumulation of anthracyclines when combined with heat.

Authors:  Y Sakaguchi; Y Maehara; S Inutsuka; I Takahashi; M Yoshida; Y Emi; H Baba; K Sugimachi
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.